These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24231351)

  • 1. Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression.
    Mueller C; Chulay JD; Trapnell BC; Humphries M; Carey B; Sandhaus RA; McElvaney NG; Messina L; Tang Q; Rouhani FN; Campbell-Thompson M; Fu AD; Yachnis A; Knop DR; Ye GJ; Brantly M; Calcedo R; Somanathan S; Richman LP; Vonderheide RH; Hulme MA; Brusko TM; Wilson JM; Flotte TR
    J Clin Invest; 2013 Dec; 123(12):5310-8. PubMed ID: 24231351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy.
    Brantly ML; Chulay JD; Wang L; Mueller C; Humphries M; Spencer LT; Rouhani F; Conlon TJ; Calcedo R; Betts MR; Spencer C; Byrne BJ; Wilson JM; Flotte TR
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16363-8. PubMed ID: 19706466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency.
    Mueller C; Gernoux G; Gruntman AM; Borel F; Reeves EP; Calcedo R; Rouhani FN; Yachnis A; Humphries M; Campbell-Thompson M; Messina L; Chulay JD; Trapnell B; Wilson JM; McElvaney NG; Flotte TR
    Mol Ther; 2017 Jun; 25(6):1387-1394. PubMed ID: 28408179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results.
    Flotte TR; Trapnell BC; Humphries M; Carey B; Calcedo R; Rouhani F; Campbell-Thompson M; Yachnis AT; Sandhaus RA; McElvaney NG; Mueller C; Messina LM; Wilson JM; Brantly M; Knop DR; Ye GJ; Chulay JD
    Hum Gene Ther; 2011 Oct; 22(10):1239-47. PubMed ID: 21609134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults.
    Brantly ML; Spencer LT; Humphries M; Conlon TJ; Spencer CT; Poirier A; Garlington W; Baker D; Song S; Berns KI; Muzyczka N; Snyder RO; Byrne BJ; Flotte TR
    Hum Gene Ther; 2006 Dec; 17(12):1177-86. PubMed ID: 17115945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Delivery of Alpha-1-Antitrypsin Using Recombinant Adeno-Associated Virus (rAAV).
    Song S; Lu Y
    Methods Mol Biol; 2018; 1826():183-196. PubMed ID: 30194601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method.
    Chulay JD; Ye GJ; Thomas DL; Knop DR; Benson JM; Hutt JA; Wang G; Humphries M; Flotte TR
    Hum Gene Ther; 2011 Feb; 22(2):155-65. PubMed ID: 20812844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects.
    Song S; Scott-Jorgensen M; Wang J; Poirier A; Crawford J; Campbell-Thompson M; Flotte TR
    Mol Ther; 2002 Sep; 6(3):329-35. PubMed ID: 12231168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone.
    Cramer ML; Shao G; Rodino-Klapac LR; Chicoine LG; Martin PT
    Hum Gene Ther; 2017 Jun; 28(6):493-509. PubMed ID: 28345428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors.
    Song S; Morgan M; Ellis T; Poirier A; Chesnut K; Wang J; Brantly M; Muzyczka N; Byrne BJ; Atkinson M; Flotte TR
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14384-8. PubMed ID: 9826709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of gene therapy for α-1 antitrypsin deficiency.
    Loring HS; Flotte TR
    Expert Opin Biol Ther; 2015 Mar; 15(3):329-36. PubMed ID: 25363251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors.
    Lu Y; Song S
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17158-62. PubMed ID: 19805176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector.
    Lu Y; Choi YK; Campbell-Thompson M; Li C; Tang Q; Crawford JM; Flotte TR; Song S
    J Gene Med; 2006 Jun; 8(6):730-5. PubMed ID: 16518879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical characterization of a recombinant adeno-associated virus type 1-pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites.
    Flotte TR; Conlon TJ; Poirier A; Campbell-Thompson M; Byrne BJ
    Hum Gene Ther; 2007 Mar; 18(3):245-56. PubMed ID: 17376008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue-derived mesenchymal stem cell-based liver gene delivery.
    Li H; Zhang B; Lu Y; Jorgensen M; Petersen B; Song S
    J Hepatol; 2011 May; 54(5):930-8. PubMed ID: 21168381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.
    Song S; Embury J; Laipis PJ; Berns KI; Crawford JM; Flotte TR
    Gene Ther; 2001 Sep; 8(17):1299-306. PubMed ID: 11571566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle-Directed Delivery of an AAV1 Vector Leads to Capsid-Specific T Cell Exhaustion in Nonhuman Primates and Humans.
    Gernoux G; Gruntman AM; Blackwood M; Zieger M; Flotte TR; Mueller C
    Mol Ther; 2020 Mar; 28(3):747-757. PubMed ID: 31982038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for α-1-antitrypsin deficiency.
    Calcedo R; Somanathan S; Qin Q; Betts MR; Rech AJ; Vonderheide RH; Mueller C; Flotte TR; Wilson JM
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1655-1659. PubMed ID: 28137880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector.
    Conlon TJ; Cossette T; Erger K; Choi YK; Clarke T; Scott-Jorgensen M; Song S; Campbell-Thompson M; Crawford J; Flotte TR
    Mol Ther; 2005 Nov; 12(5):867-75. PubMed ID: 16085464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs.
    Halbert CL; Madtes DK; Vaughan AE; Wang Z; Storb R; Tapscott SJ; Miller AD
    Mol Ther; 2010 Jun; 18(6):1165-72. PubMed ID: 20372105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.